Imexpharm Corporation announced earnings results for the first nine months of 2019. For the period, the company reported total revenue of VND 903.4 billion and profit before tax of VND 137.4 billion.

The company provided earnings guidance for the full year 2019. For the period, the company expected total revenue of VND 1,400 billion and profit before tax of VND 220 billion.